A Massachusetts company is transforming the way breast cancer is detected in real time. Newton-based Lumicell launched its ...

Positive Phase 1 Trial Data in Non-Muscle Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress; ...

At a press conference at the Baptist Health IcePlex, the American Cancer Society (ACS) announced today the launch of ...

BioAFM instruments are designed to measure soft, fragile, and complex samples, including single molecules, nucleic acids, ...

In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

Having a tattoo has been linked to a higher risk of conditions like lymphoma and skin cancer, but the situation isn't ...

Researchers and pediatric neurosurgeons at the University of Pittsburgh School of Medicine and UPMC Children's Hospital of Pittsburgh developed a new way to profile brain cancers in children, paving ...

According to a recent study published in the journal Nature Communications, UNSW scientists are exploring nanomedicine to develop more affordable and environmentally friendly agrichemicals.

This study reveals that Fe-doped boron nitride nanoparticles improve Anastrozole delivery, offering enhanced stability and targeted therapy for breast cancer.

Alex Scharfman's A24 movie 'Death of a Unicorn' mixes 'Knives Out' and 'Jurassic Park' for a toothless big pharma satire.

As biomarker testing and the demand for tumor-agnostic therapies rise, ROZLYTREK can potentially target a specialized yet valuable market segment. While competition from other TRK inhibitors ...